Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer

Journal of the National Cancer Institute

Volumn 95, Issue 2, 2003, Pages 154-159

  Shaheen, Nicholas J ^a   Silverman, Lawrence M ^b   Keku, Temitope ^a   Lawrence, Laura B ^a   Rohlfs, Elizabeth M ^b   Martin, Christopher F ^c   Galanko, Joseph ^c   Sandler, Robert S ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DNA; HFE PROTEIN; IRON; NONSTEROID ANTIINFLAMMATORY AGENT; RESTRICTION ENDONUCLEASE;

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; DNA EXTRACTION; ENVIRONMENTAL EXPOSURE; FEMALE; FISHER EXACT TEST; FOOD INTAKE; GENDER; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE DETECTION; HUMAN; IRON INTAKE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAT; POPULATION RESEARCH; PRIORITY JOURNAL; RACE; RESTRICTION MAPPING; RISK ASSESSMENT; UNITED STATES;

EID: 0037440257     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.2.154     Document Type: Article

References (40)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32.
3. Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliovaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer 1994;56:379-82.
4. Stevens RG. Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N Engl J Med 1988;319:1047-52.
5. Tseng M, Greenberg ER, Sandier RS, Baron JA, Haile RW, Blumberg BS, et al. Serum ferritin concentration and recurrence of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2000;9:625-30.
6. Siegers CP, Bumann D, Trepkau HD, Schadwinkel B, Baretton G. Role of iron in cell proliferation and tumorigenesis. Prog Clin Biol Res 1991;369:439-44.
7. Bacon BR. Diagnosis and management of hemochromatosis. Gastroenterology 1997;113:995-9.
8. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
9. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000;133:329-37.
10. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
11. Steinberg KK, Cogswell ME, Chang JC, Caudill SP, McQuillan GM, Bowman BA, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001;285:2216-22.
12. National Cancer Institute. SEER cancer statistics review, 1973-1999. http://seer.cancer.gov/csr/1973_1999/colorect.pdf.
13. Weinberg CR, Wacholder S. The design and analysis of case-control studies with biased sampling. Biometrics 1990;46:963-75.
14. Weinberg CR, Sandler DP. Randomized recruitment in case-control studies. Am J Epidemiol 1991;134:421-32.
15. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-69.
16. Jorde LB, Carey JC, Bamshad MJ, White RL. Medical genetics. 2nd ed. St. Louis (MO): Mosby; 2000. p. 58-63.
17. Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990;12:20-5.
18. Nelson RL, Davis FG, Sutter E, Sobin LH, Kikendall JW, Bowen P. Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst 1994;86:455-60.
19. Bird CL, Witte JS, Swendseid ME, Shikany JM, Hunt IF, Frankl HD, et al. Plasma ferritin, iron intake, and the risk of colorectal polyps. Am J Epidemiol 1996;144:34-41.
20. Kato I, Dnistrian AM, Schwartz M, Toniolo P, Koenig K, Shore RE, et al. Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study. Int J Cancer 1999;80:693-8.
21. Herrinton LJ, Friedman GD, Baer D, Selby JV. Transferrin saturation and risk of cancer. Am J Epidemiol 1995;142:692-8.
22. van Asperen IA, Feskens EJ, Bowles CH, Kromhout D. Body iron stores and mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men and women. Int J Epidemiol 1995;24:665-70.
23. Wurzelmann JI, Silver A, Schreinemachers DM, Sandler RS, Everson RB. Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1996;5:503-7.
24. Kuratko CN. Decrease of manganese superoxide dismutase activity in rats fed high levels of iron during colon carcinogenesis. Food Chem Toxicol 1998;36:819-24.
25. Hann HW, Stahlhut MW, Blumberg BS. Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res 1988;48:4168-70.
26. Siegers CP, Bumann D, Baretton G, Younes M. Dietary iron enhances the tumor rate in dimethylhydrazine-induced colon carcinogenesis in mice. Cancer Lett 1988;41:251-6.
27. Siegers CP, Bumann D, Trepkau HD, Schadwinkel B, Baretton G. Influence of dietary iron overload on cell proliferation and intestinal tumorigenesis in mice. Cancer Lett 1992;65:245-9.
28. Niederau C. Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
29. Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg 1995;1:237-41.
30. Hsing AW, McLaughlin JK, Olsen JH, Mellemkjar L, Wacholder S, Fraumeni JF Jr. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer 1995;60:160-2.
31. Strohmeyer G, Niederau C, Stremmel W. Survival and causes of death in hemochromatosis. Observations in 163 patients. Ann N Y Acad Sci 1988;526:245-57.
32. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992;15:655-9.
33. Tiniakos G, Williams R. Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis. Study of 71 patients treated with venesection therapy. Appl Pathol 1988;6:128-38.
34. Ammann RW, Muller E, Bansky J, Schuler G, Hacki WH. High incidence of extrahepatic carcinomas in idiopathic hemochromatosis. Scand J Gastroenterol 1980;15:733-6.
35. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-62.
36. Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, Axelsen EM, et al. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst 1985;75:81-4.
37. Nelson RL, Davis FG, Persky V, Becker E. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995;76:875-9.
38. Macdonald GA, Tarish J, Whitehall VJ, McCann SJ, Mellick GD, Buttenshaw RL, et al. No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation. J Gastroenterol Hepatol 1999;14:1188-91.
39. Altes A, Gimferrer E, Capella G, Barcelo MJ, Baiget M. Colorectal cancer and HFE gene mutations. Haematologica 1999;84:479-80.
40. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000;140:98-104.